Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-12-19
2006-12-19
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C548S519000, C548S145000, C548S347100, C548S518000, C546S208000, C546S193000, C546S268400, C546S184000, C544S359000, C544S106000, C514S461000, C514S617000, C514S514000, C514S422000, C564S133000
Reexamination Certificate
active
07151118
ABSTRACT:
Compounds of formula (I):or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
REFERENCES:
patent: 4200750 (1980-04-01), Warner et al.
patent: 4968677 (1990-11-01), Riebli
patent: 4968804 (1990-11-01), Stanek et al.
patent: 5064832 (1991-11-01), Stanek et al.
patent: 5236934 (1993-08-01), VanAtten
patent: 5246943 (1993-09-01), Blankley et al.
patent: 5521213 (1996-05-01), Prasit et al.
patent: 5534518 (1996-07-01), Henrie et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5858995 (1999-01-01), Kawai et al.
patent: 5877190 (1999-03-01), Dhainaut et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 5945418 (1999-08-01), Bemis et al.
patent: 5977103 (1999-11-01), Adams et al.
patent: 6060491 (2000-05-01), Pruitt et al.
patent: 6080767 (2000-06-01), Klein et al.
patent: 6087496 (2000-07-01), Anantanarayan et al.
patent: 6130235 (2000-10-01), Mavunkel et al.
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6174887 (2001-01-01), Haruta et al.
patent: 6251914 (2001-06-01), Adams et al.
patent: 6277989 (2001-08-01), Chakravarty et al.
patent: 6323227 (2001-11-01), Klein et al.
patent: 6392047 (2002-05-01), Geissler et al.
patent: 6399627 (2002-06-01), Song et al.
patent: 6420561 (2002-07-01), Haruta et al.
patent: 6436925 (2002-08-01), Lubisch et al.
patent: 6448257 (2002-09-01), Mavunkel et al.
patent: 6451794 (2002-09-01), Beswick et al.
patent: 6498166 (2002-12-01), Campbell et al.
patent: 6509363 (2003-01-01), Salituro et al.
patent: 6545054 (2003-04-01), Song et al.
patent: 6509361 (2003-05-01), Weier et al.
patent: 6576632 (2003-06-01), Goldstein et al.
patent: 6579872 (2003-06-01), Brown et al.
patent: 6605625 (2003-08-01), Peukert et al.
patent: 6638980 (2003-10-01), Su et al.
patent: 6696464 (2004-02-01), McClure et al.
patent: 6699994 (2004-03-01), Babu et al.
patent: 6774127 (2004-08-01), Adams et al.
patent: 6794377 (2004-09-01), Peukert et al.
patent: 6821965 (2004-11-01), Brown et al.
patent: 6855719 (2005-02-01), Thomas et al.
patent: 6867209 (2005-03-01), Mavunkel et al.
patent: 6924392 (2005-08-01), Peukert et al.
patent: 6936719 (2005-08-01), Babu et al.
patent: 6956037 (2005-10-01), Brown et al.
patent: 2001/0011135 (2001-08-01), Reidl et al.
patent: 2003/0055088 (2003-03-01), Shao et al.
patent: 2003/0139605 (2003-07-01), Riedl et al.
patent: 2003/0225089 (2003-12-01), Jung et al.
patent: 2004/0038858 (2004-02-01), Dorsch et al.
patent: 2004/0053942 (2004-03-01), Alberti et al.
patent: 2004/0116479 (2004-06-01), Haviv et al.
patent: 2004/0128287 (2004-07-01), Barth et al.
patent: 2004/0162281 (2004-08-01), Babu et al.
patent: 2004/0176446 (2004-09-01), Alonso-Alija et al.
patent: 2004/0242868 (2004-12-01), Angell et al.
patent: 2004/0249161 (2004-12-01), Angell et al.
patent: 2004/0254200 (2004-12-01), Davis et al.
patent: 2004/0266839 (2004-12-01), Angell et al.
patent: 2004/0267012 (2004-12-01), Angell et al.
patent: 2005/0020590 (2005-01-01), Lang et al.
patent: 2005/0038014 (2005-02-01), Angell et al.
patent: 2005/0065195 (2005-03-01), Angell et al.
patent: 2005/0090491 (2005-04-01), Angell et al.
patent: 2005/0176964 (2005-08-01), Aston et al.
patent: 0 533 268 (1992-09-01), None
patent: 0 533 266 (1993-03-01), None
patent: 0 430 033 (2004-04-01), None
patent: 2 273 930 (1993-12-01), None
patent: 2 276 161 (1994-09-01), None
patent: 2 276 162 (1994-09-01), None
patent: 2 295 387 (1996-05-01), None
patent: 11218884 (1999-08-01), None
patent: WO 94/15920 (1994-07-01), None
patent: WO 95/06636 (1995-03-01), None
patent: WO 95/06644 (1995-03-01), None
patent: WO 95/11243 (1995-04-01), None
patent: 95/15954 (1995-06-01), None
patent: WO 95/17401 (1995-06-01), None
patent: WO 95/29907 (1995-11-01), None
patent: WO 95/30675 (1995-11-01), None
patent: WO 96/31508 (1996-10-01), None
patent: WO 96/31509 (1996-10-01), None
patent: WO 97/03034 (1997-01-01), None
patent: WO 98/57934 (1998-12-01), None
patent: 99/32463 (1999-07-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/12497 (2000-03-01), None
patent: WO 00/26216 (2000-05-01), None
patent: WO 00/56738 (2000-09-01), None
patent: 00/71535 (2000-11-01), None
patent: WO 00/71493 (2000-11-01), None
patent: WO 00/71509 (2000-11-01), None
patent: WO 00/71510 (2000-11-01), None
patent: WO 00/71511 (2000-11-01), None
patent: WO 01/27089 (2001-04-01), None
patent: WO 01/34605 (2001-05-01), None
patent: WO 01/70695 (2001-09-01), None
patent: 01/87875 (2001-11-01), None
patent: WO 02/40486 (2002-05-01), None
patent: WO 03/032970 (2003-04-01), None
patent: WO 03/068747 (2003-08-01), None
patent: WO 03/093248 (2003-11-01), None
patent: WO 04/010995 (2004-02-01), None
patent: WO 04/089874 (2004-10-01), None
patent: WO 04/089875 (2004-10-01), None
patent: WO 04/089876 (2004-10-01), None
patent: WO 05/014550 (2005-02-01), None
patent: WO 05/073189 (2005-08-01), None
patent: WO 05/073217 (2005-08-01), None
patent: WO 05/073219 (2005-08-01), None
patent: WO 05/073232 (2005-08-01), None
Boehm et al.,Expert Opinion of Therapeutic Patents, vol. 10 (1) pp. 25-37 (2000).
Boehm, et al,Journal of Medicinal Chemistry, vol. 39(20) pp. 3929-3937 (1996).
Ceccarelli et al.,European Journal of Medicinal Chemistry, vol. 33 (12) pp. 943-955 (1998).
Gabriele et al.,European Journal of Organic Chemistry, vol. 2001 (24) pp. 4607-4613 (2001)
Han et al.,Biohemica et Biophysica Acta—Molecular Cell Research, vol. 1265 (2-3) pp. 224-227 (1995.
Hanson,Expert Opinion on Therapeutic Patents, vol 7(7) pp. 729-733 (1997).
Henry et al.,Drugs of the Future, vol. 24 (12) pp. 1345-1354 (1999).
Jiang et al,Journal of Biological Chemistry, vol. 271 (30) pp. 17920-17926 (1996).
Li et al.,Biochemical and Biophysical Research Communications, vol. 228 (2) pp. 334-340 (1996).
Liebeskind et al.,Organic Letters, vol. 4 (6) pp. 979-981 (2002).
Moreland et al.,Annals of Internal Medicine, vol. 130 (6) pp. 478-486 (1999).
Murali Dhar et al.,Bioorganic and Medicinal Chemistry Letters, vol. 12 (21) pp. 3125-3128 (2002).
Rankin et al.,British Journal of Rheumatology, vol. 34 pp. 334-342 (1995).
Salituro et al.,Current Medicinal Chemistry, vol. 6 pp. 807-823 (1999).
Wang et al.,Journal of Biological Chemistry, vol. 272 (38) pp. 23668-23674 (1997).
U.S. Appl. No. 10/513,095, filed Aug. 26, 2005, Angell et al.
U.S. Appl. No. 10/492,714, filed Apr. 15, 2004, Angell et al.
U.S. Appl. No. 10/568,121, filed Feb. 9, 2006, Walker, A.
U.S. Appl. No. 10/522,955, filed Nov. 11, 2005, Angell et al.
U.S. Appl. No. 10/551,503, filed Sep. 30, 2005, Aston, N.
U.S. Appl. No. 10/551,501, filed Sep. 30, 2005, Aston, N.
U.S. Appl. No. 10/551,502, filed Sep. 30, 2005, Aston, et al.
Boehm, et al.,Expert Opinion on Therapeutic Patents, vol. 10(1), pp. 25-37 (2000).
Courtney, S. et al.,Bioorganic&Medicinal Chemistry Letters, vol. 14 pp. 3269-3273 (2004).
Foster, et al.,Drug News Perspect., vol. 13(8) pp. 488-497 (2000).
Hanson, G., Expert Opinion on Therapeutic Patents, vol. 7(7) pp. 729-733 (1997).
Henry, et al.,Bioorganic&Medicinal Chemistry Letters, vol. 8 pp. 3335-3340 (1998).
Herlaar, et al., Molecular Medicine Today, vol. 5 pp. 439-447 (1999).
Marin, et al.,Blood, vol. 98(3) pp. 667-673 (2001).
Underwood, et al.,Journal of Pharmacology and Experimental Therapeutics, vol. 293 (1) pp. 281-288 (2000).
Wadsworth, et al., Journal of Pharmacology and Experimental Therapeutics, vol. 291(2) pp. 680-687 (1999).
Angell Richard Martyn
Aston Nicola Mary
Bamborough Paul
Bamford Mark James
Cockerill George Stuart
Chu Yong
Dinner Dara L.
Glaxo Group Limited
Kinzig Charles M.
McKane Joseph K.
LandOfFree
Biphenylcarboxylic amide derivatives as p38-kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biphenylcarboxylic amide derivatives as p38-kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenylcarboxylic amide derivatives as p38-kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3710835